Mesenchymal stem cells and bone regeneration: current status.
about
Use of platelet lysate for bone regeneration - are we ready for clinical translation?Immunomodulation by mesenchymal stem cells in veterinary speciesThe Possible Roles of Biological Bone Constructed with Peripheral Blood Derived EPCs and BMSCs in Osteogenesis and AngiogenesisSurgical sutures filled with adipose-derived stem cells promote wound healingPDGF-induced PI3K-mediated signaling enhances the TGF-β-induced osteogenic differentiation of human mesenchymal stem cells in a TGF-β-activated MEK-dependent mannerUpdates in biological therapies for knee injuries: bone.Shaping oral cell plasticity to osteogenic differentiation by human mesenchymal stem cell coculture.In situ printing of mesenchymal stromal cells, by laser-assisted bioprinting, for in vivo bone regeneration applications.MCP/CCR2 signaling is essential for recruitment of mesenchymal progenitor cells during the early phase of fracture healing.Paracrine effect of mesenchymal stem cells derived from human adipose tissue in bone regeneration.Neurogenic differentiation of human dental stem cells in vitroA sulfated nanofibrous mesh supporting the osteogenic differentiation of periosteum-derived cells.Decellularized tissue-engineered heart valve leaflets with recellularization potentialAutologous serum improves bone formation in a primary stable silica-embedded nanohydroxyapatite bone substitute in combination with mesenchymal stem cells and rhBMP-2 in the sheep modelTotal body irradiation is permissive for mesenchymal stem cell-mediated new bone formation following local transplantation.Stem cell therapy for the treatment of early stage avascular necrosis of the femoral head: a systematic reviewOsteogenic cell fractions isolated from mouse tongue muscleGene expression changes in human mesenchymal stem cells from patients with osteoporosis.miR-125b Is an adhesion-regulated microRNA that protects mesenchymal stem cells from anoikis.Heterologous mesenchymal stem cells successfully treat femoral pseudarthrosis in rats.TLR4 Activation Promotes Bone Marrow MSC Proliferation and Osteogenic Differentiation via Wnt3a and Wnt5a Signaling"Cleaning" the Surface of Hydroxyapatite Nanorods by a Reaction-Dissolution Approach.Mesenchymal stem cell expression of stromal cell-derived factor-1β augments bone formation in a model of local regenerative therapy.MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometrySurface tethered epidermal growth factor protects proliferating and differentiating multipotential stromal cells from FasL-induced apoptosis.Inhibition of IL-1R1/MyD88 signalling promotes mesenchymal stem cell-driven tissue regenerationConcise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectivesThe promise and challenges of stem cell-based therapies for skeletal diseases: stem cell applications in skeletal medicine: potential, cell sources and characteristics, and challenges of clinical translationWnt signaling behaves as a "master regulator" in the osteogenic and adipogenic commitment of human amniotic fluid mesenchymal stem cells.Osteogenic, stem cell and molecular characterisation of the human induced membrane from extremity bone defectsDual delivery of rhPDGF-BB and bone marrow mesenchymal stromal cells expressing the BMP2 gene enhance bone formation in a critical-sized defect model.Collagen-containing scaffolds enhance attachment and proliferation of non-cultured bone marrow multipotential stromal cellsInhibition of connexin 43 prevents trauma-induced heterotopic ossification.A glycosaminoglycan based, modular tissue scaffold system for rapid assembly of perfusable, high cell density, engineered tissues.In situ guided tissue regeneration in musculoskeletal diseases and aging : Implementing pathology into tailored tissue engineering strategies.Organ repair and regeneration: an overview.Polymeric biomaterials for stem cell bioengineering.Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.Concise review: combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy.The RESOLVE concept: approaching pathophysiology of fibroproliferative disease in aged individuals.
P2860
Q26765255-3FA3366C-6626-4413-AAFB-ABB774E1C3BDQ26822818-03782573-2BD5-4E91-B7C9-796FBE6025EEQ27349456-59CA0A82-2117-4CF6-A943-10FBA545D5E1Q28540862-908AA8CC-2698-45B8-85FF-D43AF378F189Q28658995-8A723BFF-92A9-4D1D-9B79-E7ADADAE02F6Q30401258-6B65E047-B45C-4425-9F82-3F265567AEE7Q33357594-0A9E0C8A-ED27-42C8-8506-D1B3ED118826Q33686781-343527CD-F7F0-462C-9C82-7C47D74EB161Q34061791-08DD8441-2381-43A3-BC36-B5C95F94338BQ34150013-18632F03-9F6E-4C36-9596-134C336E0EE7Q34221978-8BB02D14-93F4-4BE3-8953-4ACE6255A34FQ34323750-6798A73A-D5A4-41BE-8D76-82888D57BC14Q34454174-11F28F35-6118-46CA-A1C1-5FF941924E7FQ34565064-A2B8AA98-8280-41C3-B23F-D95A47B454FAQ34652682-F244C596-05D1-4278-AD74-EA10CE738B2DQ35179593-8F555E91-F9C0-42DA-B859-C6394C4D57AAQ35628343-AAC822DF-1F53-4438-BC32-5EE7570D533DQ35628505-CDCC6558-8CB1-4DBC-9DF9-AF5A5CB0E11FQ35881512-92FCFC32-9C97-4AC7-A426-CE20251417BBQ35907874-5BD0C91C-9273-4C0D-ACDB-8F973538B39EQ35941309-0EB82588-1A6F-4CA6-8CF1-390A7439F176Q36362100-5A1FA814-189A-4A1F-8414-ABC9DF82E6DEQ36445537-E0C3B5CA-8E39-48C4-89AD-019C4BD9F6BEQ36454220-4443E320-175A-402E-AD91-CEF665C81171Q36484494-167BF15B-CF7D-4B4B-8247-D108C9DFAE0CQ36719155-147D403D-7050-4533-9A04-910E12200E8DQ36862085-5468FFC5-0164-46B1-BA54-B66075F3BDE1Q36965820-B53EF2BD-2F47-49D3-B198-8CEFF6ECC0D3Q37202311-44C057A3-593B-4A75-B56A-20BA083F7782Q37227629-9BA903C7-52F7-4284-8363-8E4F868ED164Q37253278-9C5D2908-EF49-42E4-95A2-C54BAA9449EAQ37337348-6A47B9B3-3D81-42FC-AA01-C5C96CD580EFQ37416877-9C1E447F-A853-4900-AD56-DF5DAEA95E44Q37495735-4F913C2A-7BAB-4EEC-9EDA-5C7287D840C8Q37947420-C7D50424-8B8D-40DB-86A0-6672F4E55758Q37997980-BCC54490-88EE-49EB-845E-CBA2F7ECAB12Q38034173-79FFFE15-9F82-4198-9E4A-8A60FD0F7408Q38068244-A5D45BEF-AEFE-4C37-BB72-F1C2FDE113D4Q38127160-DE6965FB-7A51-418F-85C3-7E3461DC3FF5Q38129218-3AAC1894-2102-4FC3-B254-5C55F62406D5
P2860
Mesenchymal stem cells and bone regeneration: current status.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mesenchymal stem cells and bone regeneration: current status.
@en
Mesenchymal stem cells and bone regeneration: current status.
@en-gb
Mesenchymal stem cells and bone regeneration: current status.
@nl
type
label
Mesenchymal stem cells and bone regeneration: current status.
@en
Mesenchymal stem cells and bone regeneration: current status.
@en-gb
Mesenchymal stem cells and bone regeneration: current status.
@nl
prefLabel
Mesenchymal stem cells and bone regeneration: current status.
@en
Mesenchymal stem cells and bone regeneration: current status.
@en-gb
Mesenchymal stem cells and bone regeneration: current status.
@nl
P1433
P1476
Mesenchymal stem cells and bone regeneration: current status.
@en
P304
P356
10.1016/J.INJURY.2011.03.030
P577
2011-04-13T00:00:00Z